Lung structural remodeling and pulmonary hypertension after myocardial infarction: Complete reversal with irbesartan

Cardiovascular Research

Volumn 58, Issue 3, 2003, Pages 621-631

  Jasmin, Jean François ^a   Calderone, Angelino ^a   Leung, Tack Ki ^a   Villeneuve, Louis ^a   Dupuis, Jocelyn ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Angiotensin; Heart failure; Hypertension; Pulmonary circulation; Remodeling

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; COLLAGEN; IRBESARTAN; RETICULIN;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG ACTIVITY; ELECTRON MICROSCOPY; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FILLING PRESSURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEMODYNAMIC MONITORING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUNG EDEMA; LUNG MECHANICS; LUNG PRESSURE; LUNG STRUCTURE; LUNG WEIGHT; MALE; MORPHOMETRICS; MYOFIBROBLAST; NONHUMAN; POOR GENERAL CONDITION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SHAM FEEDING; TISSUE SECTION;

ACTINS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; DESMIN; FACTOR VIII; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICROSCOPY, ELECTRON; MUSCLE CELLS; MYOCARDIAL INFARCTION; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 2; TETRAZOLES;

EID: 0037531464     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00290-6     Document Type: Article

References (32)

1. Thompson W.P., White P.D. The commonest cause of hypertrophy of the right ventricle: left ventricular strain and failure. Am Heart J. 12:1936;641.
2. Abramson S.V., Burke J.F., Kelly J.J. Jr., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 116:1992;888-895.
3. Butler J., Chomsky D.B., Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 34:1999;1802-1806.
4. Cappola T.P., Felker G.M., Kao W.H., et al. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation. 105:2002;1663-1668.
5. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 37:2001;183-188.
6. Lipworth B.J., Dagg K.D. Vasoconstrictor effects of angiotensin II on the pulmonary vascular bed. Chest. 105:1994;1360-1364.
7. 1 receptor. Chest. 114:(suppl 1):1998;90S-91S.
8. Abraham M.R., Olson L.J., Joyner M.J., et al. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive heart failure. Circulation. 106:2002;1794-1799.
9. Nguyen Q.T., Colombo F., Rouleau J.L., et al. LU135252, an endothelin (A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction. Br J Pharmacol. 130:2000;1525-1530.
10. Hill M.F., Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol. 148:1996;291-300.
11. Saito T., Hu F., Tayara L., et al. Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am J Physiol (Heart Circ Physiol). 283:2002;H339-H345.
12. Kapanci Y., Burgan S., Pietra G.G., et al. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am J Pathol. 136:1990;881-889.
13. Leslie K.O., Mitchell J., Low R. Lung myofibroblasts. Cell Motil Cytoskeleton. 22:1992;92-98.
14. Shepro D., Morel N.M. Pericyte physiology. FASEB J. 7:1993;1031-1038.
15. Sims D.E. Diversity within pericytes. Clin Exp Pharmacol Physiol. 27:2000;842-846.
16. Sims D.E., Westfall J.A. Analysis of relationships between pericytes and gas exchange capillaries in neonatal and mature bovine lungs. Microvasc Res. 25:1983;333-342.
17. Tilton R.G., Kilo C., Williamson J.R. Pericyte-endothelial relationships in cardiac and skeletal muscle capillaries. Microvasc Res. 18:1979;325-335.
18. Herman I.M., D'Amore P.A. Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol. 101:1985;43-52.
19. Skalli O., Pelte M.F., Peclet M.C., et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem. 37:1989;315-321.
20. Crocker D.J., Murad T.M., Geer J.C. Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol. 13:1970;51-65.
21. Canfield A.E., Allen T.D., Grant M.E., et al. Modulation of extracellular matrix biosynthesis by bovine retinal pericytes in vitro: effects of the substratum and cell density. J Cell Sci. 96:1990;159-169.
22. Schor A.M., Canfield A.E., Sloan P., et al. Differentiation of pericytes in culture is accompanied by changes in the extracellular matrix. In Vitro Cell Dev Biol. 27A:1991;651-659.
23. Eskenasy M., Tasca S.I. Culture of pericytes isolated from rat adipose microvasculature and characterization of their prostanoid production. Cell Biol Int Rep. 12:1988;1055-1066.
24. Hudes G.R., Li W.Y., Rockey J.H., et al. Prostacyclin is the major prostaglandin synthesized by bovine retinal capillary pericytes in culture. Invest Ophthalmol Vis Sci. 29:1988;1511-1516.
25. Takahashi K., Brooks R.A., Kanse S.M., et al. Production of endothelin 1 by cultured bovine retinal endothelial cells and presence of endothelin receptors on associated pericytes. Diabetes. 38:1989;1200-1202.
26. Wakui S. Epidermal growth factor receptor at endothelial cell and pericyte interdigitation in human granulation tissue. Microvasc Res. 44:1992;255-262.
27. Jackson J.A., Carlson E.C. Inhibition of bovine retinal microvascular pericyte proliferation in vitro by adenosine. Am J Physiol. 263:1992;H634-H640.
28. Dodge A.B., D'Amore P.A. Cell-cell interactions in diabetic angiopathy. Diabetes Care. 15:1992;1168-1180.
29. Lee T.S., Hu K.Q., Chao T., et al. Characterization of endothelin receptors and effects of endothelin on diacylglycerol and protein kinase C in retinal capillary pericytes. Diabetes. 38:1989;1643-1646.
30. Meyrick B., Reid L. Ultrastructural features of the distended pulmonary arteries of the normal rat. Anat Rec. 193:1979;71-97.
31. Nadal J.A., Scicli G.M., Carbini L.A., et al. Angiotensin II and retinal pericytes migration. Biochem Biophys Res Commun. 266:1999;382-385.
32. Otani A., Takagi H., Oh H., et al. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Invest Ophthalmol Vis Sci. 41:2000;1192-1199.